S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
Options Trading Plan–Perfect For Beginners (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Options Trading Plan–Perfect For Beginners (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
MarketBeat's Top 5 Stock Picks - Just Released (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
Options Trading Plan–Perfect For Beginners (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Options Trading Plan–Perfect For Beginners (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
MarketBeat's Top 5 Stock Picks - Just Released (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
Options Trading Plan–Perfect For Beginners (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Options Trading Plan–Perfect For Beginners (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
MarketBeat's Top 5 Stock Picks - Just Released (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
Options Trading Plan–Perfect For Beginners (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
Options Trading Plan–Perfect For Beginners (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
MarketBeat's Top 5 Stock Picks - Just Released (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
NASDAQ:CALC

CalciMedica (CALC) Stock Forecast, Price & News

$2.64
-0.11 (-4.00%)
(As of 09/22/2023 ET)
Compare
Today's Range
$2.59
$2.99
50-Day Range
$2.64
$3.87
52-Week Range
$1.00
$8.59
Volume
8,990 shs
Average Volume
6,856 shs
Market Capitalization
$14.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CALC stock logo

About CalciMedica (NASDAQ:CALC) Stock

CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.

CALC Price History

CALC Stock News Headlines

CalciMedica (NASDAQ:CALC) Shares Down 4%
2,164% from AI stock in a... month?
That's the potential of Multi-millionaire trader Nate Bear's new strategy he calls "One Ticker Payouts". It involves one ticker...one trade...every week. How is this possible?  Click here to see all the details and proof for yourself (the next One Ticker Payout is this upcoming MONDAY)>>
CalciMedica Inc.
CALC - CalciMedica, Inc.
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
CalciMedica Announces Relisting on Nasdaq
CalciMedica Inc Ordinary Shares
See More Headlines
Receive CALC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CalciMedica and its competitors with MarketBeat's FREE daily newsletter.

CALC Company Calendar

Last Earnings
8/10/2023
Today
9/24/2023
Next Earnings (Estimated)
11/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CALC
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

Net Income
$-35,600,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$23.35 per share

Miscellaneous

Free Float
2,644,000
Market Cap
$14.94 million
Optionable
Not Optionable
Beta
1.08
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. A. Rachel Leheny Ph.D. (Age 60)
    CEO & Director
  • Mr. Eric W. Roberts (Age 59)
    Chief Bus. Officer & Vice Chairman
  • Mr. Michael J. Dunn MBA (Age 67)
    Pres & COO
  • Dr. Anjana Rao Ph.D.
    Co-Founder and Scientific Advisor
  • Dr. Patrick Hogan Ph.D.
    Co-Founder and Scientific Advisor
  • Dr. Stefan Feske M.D.
    Co-Founder and Scientific Advisor
  • Dr. Kenneth A. Stauderman Ph.D. (Age 70)
    Co-Founder & Chief Scientific Officer
  • Mr. Daniel E. Geffken M.B.A. (Age 66)
    MBA, Interim Chief Financial Officer
  • Cindy Reiedenberg
    Accountant
  • Mr. John M. Dunn J.D. (Age 71)
    Gen. Counsel













CALC Stock - Frequently Asked Questions

Should I buy or sell CalciMedica stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CalciMedica in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" CALC shares.
View CALC analyst ratings
or view top-rated stocks.

How have CALC shares performed in 2023?

CalciMedica's stock was trading at $5.71 at the beginning of 2023. Since then, CALC shares have decreased by 53.8% and is now trading at $2.64.
View the best growth stocks for 2023 here
.

When is CalciMedica's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our CALC earnings forecast
.

How were CalciMedica's earnings last quarter?

CalciMedica, Inc. (NASDAQ:CALC) announced its earnings results on Thursday, August, 10th. The company reported ($1.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.02) by $0.09.

What is CalciMedica's stock symbol?

CalciMedica trades on the NASDAQ under the ticker symbol "CALC."

Who are CalciMedica's major shareholders?

CalciMedica's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BML Capital Management LLC (1.57%) and Meritage Portfolio Management (0.18%).
View institutional ownership trends
.

How do I buy shares of CalciMedica?

Shares of CALC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CalciMedica's stock price today?

One share of CALC stock can currently be purchased for approximately $2.64.

How much money does CalciMedica make?

CalciMedica (NASDAQ:CALC) has a market capitalization of $14.94 million.

How can I contact CalciMedica?

CalciMedica's mailing address is 203 REDWOOD SHORES PARKWAY SUITE 620, REDWOOD CITY CA, 94065. The official website for the company is www.graybug.vision. The company can be reached via phone at 858-952-5500 or via email at ir@graybug.vision.

This page (NASDAQ:CALC) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -